CapsoVision (CV) vs Orthofix Medical (OFIX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
CapsoVision (CV) has outperformed Orthofix Medical (OFIX) over the past year, gaining 43.9% versus a loss of 35.2%. Orthofix Medical is the larger company by market cap ($363.8 million vs $352.3 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CV | OFIX |
|---|---|---|
| Share price | $6.62 | $9.00 |
| Market cap | $352.25M | $363.79M |
| 1-day change | +1.22% | -2.17% |
| YTD return | -38.07% | -39.31% |
| 1-year return | +43.91% | -35.21% |
| 5-year return | — | -74.61% |
| Forward P/E | — | 24.32 |
| EPS (TTM) | $-0.45 | $-1.52 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $15.37 | $16.99 |
| 52-week low | $4.38 | $8.50 |
| Distance from 52-week high | -56.93% | -47.03% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +43.50% | +44.44% |
| Average volume | 157.18K | 369.51K |
| Shares outstanding | 53.21M | 40.42M |
| Employees | 99 | 1,605 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CV has outperformed OFIX by 79.1 percentage points over the past year.
About CapsoVision
CV stock →CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon).
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 99 employees
About Orthofix Medical
OFIX stock →Orthofix Medical Inc., together with its subsidiaries, operates as a medical technology company in the United States, Italy, the United Kingdom, France, Germany, Brazil, and internationally. It operates through two segments, Global Spine and Global Limb Reconstruction.
Health Care · Medical/Dental Instruments · 1,605 employees
CV vs OFIX FAQ
Which is bigger, CapsoVision or Orthofix Medical?
Orthofix Medical (OFIX) is larger, with a market capitalization of $363.79M compared with $352.25M for CapsoVision (CV).
Which stock has performed better over the past year, CV or OFIX?
CV returned +43.91% over the past 12 months, compared with -35.21% for OFIX (price return, excluding dividends). Past performance does not predict future results.
Are CapsoVision and Orthofix Medical in the same industry?
Both are in the Health Care sector, but in different industries: Biotechnology: Electromedical & Electrotherapeutic Apparatus for CapsoVision and Medical/Dental Instruments for Orthofix Medical.